Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.
View Top Employees from AthersysWebsite | http://www.athersys.com/ |
Ticker | ATHX |
Revenue | $6 million |
Employees | 61 (61 on RocketReach) |
Founded | 1995 |
Address | 3201 Carnegie Ave, Cleveland, Ohio 44115, US |
Phone | (216) 431-9900 |
Fax | (216) 361-9495 |
Technologies |
JavaScript,
HTML,
Twitter
+23 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Stem Cells, Healthcare, Science and Engineering, Regenerative Medicine, Health Care, Pharmaceutical |
Web Rank | 5 Million |
Keywords | Athersys, Athersys Breakthrough Designation, Aspire Capital, New Drug Application "Nda" For Stroke Research Houston Stroke, Athersys Phase 2 |
Competitors | Brainstorm Cell Therapeutics, Capricor Therapeutics, Inc., Lisata Therapeutics, Inc., Minerva Biotechnologies, Q Therapeutics |
SIC | SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 87 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Athersys employee's phone or email?
The Athersys annual revenue was $6 million in 2024.
61 people are employed at Athersys.
Athersys is based in Cleveland, Ohio.
The NAICS codes for Athersys are [32, 3254, 32541, 325].
The SIC codes for Athersys are [873, 28, 87, 283].